Skip Header

21 results for author:"Fukumoto H." in Literature citations

Page 1 of 1

to top of page·  

Results Customize

› Repeat search in UniProtKB (9)

Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype.

Blom E.S., Giedraitis V., Zetterberg H., Fukumoto H., Blennow K., Hyman B.T., Irizarry M.C., Wahlund L.O., Lannfelt L., Ingelsson M.

Dement Geriatr Cogn Disord 27:458-464(2009) · Mapped (5)

Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease.

Locascio J.J., Fukumoto H., Yap L., Bottiglieri T., Growdon J.H., Hyman B.T., Irizarry M.C.

Arch. Neurol. 65:776-785(2008) · Mapped (13)

Chymase activates promatrix metalloproteinase-9 in human abdominal aortic aneurysm.

Furubayashi K., Takai S., Jin D., Miyazaki M., Katsumata T., Inagaki S., Kimura M., Tanaka K., Nishimoto M., Fukumoto H.

Clin. Chim. Acta 388:214-216(2008) · Mapped (7)

Expression of APP pathway mRNAs and proteins in Alzheimer's disease.

Matsui T., Ingelsson M., Fukumoto H., Ramasamy K., Kowa H., Frosch M.P., Irizarry M.C., Hyman B.T.

Brain Res. 1161:116-123(2007) · Mapped (10)

A ubiquitin ligase complex assembles linear polyubiquitin chains.

Kirisako T., Kamei K., Murata S., Kato M., Fukumoto H., Kanie M., Sano S., Tokunaga F., Tanaka K., Iwai K.

EMBO J. 25:4877-4887(2006) · UniProtKB (2)

Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms.

Lee J., Fukumoto H., Orne J., Klucken J., Raju S., Vanderburg C.R., Irizarry M.C., Hyman B.T., Ingelsson M.

Exp. Neurol. 194:91-96(2005) · Mapped (6)

Notch1 competes with the amyloid precursor protein for gamma-secretase and down-regulates presenilin-1 gene expression.

Lleo A., Berezovska O., Ramdya P., Fukumoto H., Raju S., Shah T., Hyman B.T.

J. Biol. Chem. 278:47370-47375(2003) · Mapped (30)

APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.

Fukumoto H., Ingelsson M., Garevik N., Wahlund L.O., Nukina N., Yaguchi Y., Shibata M., Hyman B.T., Rebeck G.W., Irizarry M.C.

Exp. Neurol. 183:249-253(2003) · Mapped (5)

Possible roles of angiotensin II-forming enzymes, angiotensin converting enzyme and chymase-like enzyme, in the human aneurysmal aorta.

Tsunemi K., Takai S., Nishimoto M., Yuda A., Hasegawa S., Sawada Y., Fukumoto H., Sasaki S., Miyazaki M.

Hypertens. Res. 25:817-822(2002) · Mapped (4)

Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Abeta levels.

Fukumoto H., Deng A., Irizarry M.C., Fitzgerald M.L., Rebeck G.W.

J. Biol. Chem. 277:48508-48513(2002) · Mapped (2)

Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease.

Fukumoto H., Cheung B.S., Hyman B.T., Irizarry M.C.

Arch. Neurol. 59:1381-1389(2002) · Mapped (11)

Osteopontin induces angiogenesis of murine neuroblastoma cells in mice.

Takahashi F., Akutagawa S., Fukumoto H., Tsukiyama S., Ohe Y., Takahashi K., Fukuchi Y., Saijo N., Nishio K.

Int. J. Cancer 98:707-712(2002) · Mapped (11)

Interferon-gamma-inducing factor gene transfection into Lewis lung carcinoma cells reduces tumorigenicity in vivo.

Fukumoto H., Nishio M., Nishio K., Heike Y., Arioka H., Kurokawa H., Ishida T., Fukuoka K., Nomoto T., Ohe Y. et al.

Jpn. J. Cancer Res. 88:501-505(1997) · Mapped (5)

Sequence of an intestinal cDNA encoding human motilin precursor.

Seino Y., Tanaka K., Takeda J., Takahashi H., Mitani T., Kurono M., Kayano T., Koh G., Fukumoto H., Yano H. et al.

FEBS Lett. 223:74-76(1987) · UniProtKB (1)

The polymorphism linked to the human insulin gene: its lack of association with either IDDM or NIDDM in Japanese.

Takeda J., Seino Y., Fukumoto H., Koh G., Otsuka A., Ikeda M., Kuno S., Yawata M., Moridera K., Morita T.

Acta Endocrinol. 113:268-271(1986) · Mapped (3)

Sequence, tissue distribution, and chromosomal localization of mRNA encoding a human glucose transporter-like protein.

Fukumoto H., Seino S., Imura H., Sieno Y., Eddy R.L., Fukushima Y., Byers M.G., Shows T.B., Bell G.I.

Proc. Natl. Acad. Sci. U.S.A. 85:5434-5438(1988) · UniProtKB (1) · Mapped (3)

Evidence for a family of human glucose transporter-like proteins. Sequence and gene localization of a protein expressed in fetal skeletal muscle and other tissues.

Kayano T., Fukumoto H., Eddy R.L., Fan Y.-S., Byers M.G., Shows T.B., Bell G.I.

J. Biol. Chem. 263:15245-15248(1988) · UniProtKB (1) · Mapped (13)

Sequence of an intestinal cDNA encoding human gastric inhibitory polypeptide precursor.

Takeda J., Seino Y., Tanaka K., Fukumoto H., Kayano T., Takahashi H., Mitani T., Kurono M., Suzuki T., Tobe T. et al.

Proc. Natl. Acad. Sci. U.S.A. 84:7005-7008(1987) · UniProtKB (1)

Characterization and expression of human HepG2/erythrocyte glucose-transporter gene.

Fukumoto H., Seino S., Imura H., Seino Y., Bell G.I.

Diabetes 37:657-661(1988) · UniProtKB (1)

Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues.

Fukumoto H., Kayano T., Buse J.B., Edwards Y., Pilch P.F., Bell G.I., Seino S.

J. Biol. Chem. 264:7776-7779(1989) · UniProtKB (1) · Mapped (3)

Human facilitative glucose transporters. Isolation, functional characterization, and gene localization of cDNAs encoding an isoform (GLUT5) expressed in small intestine, kidney, muscle, and adipose tissue and an unusual glucose transporter pseudogene-like sequence (GLUT6).

Kayano T., Burant C.F., Fukumoto H., Gould G.W., Fan Y.-S., Eddy R.L., Byers M.G., Shows T.B., Seino S., Bell G.I.

J. Biol. Chem. 265:13276-13282(1990) · UniProtKB (1)

to top of page·

Page 1 of 1